Back to Journals

Infection and Drug Resistance

ISSN: 1178-6973

Professor Suresh Antony

Professor Antony

Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA

Professor Suresh Antony is a clinical professor with the Department of Internal Medicine at Texas Tech University Health Sciences Center. Since completing his PhD at Pacific Western University, Professor Antony has been the recipient of multiple teaching honours, including the 1994 Resident Teacher of the Year Award, presented by the ECU School of Medicine, the Teaching Award of Texas Tech University Health Sciences Center in 1998 and 1999, and the ACP-ASIM Community Based Internal Medicine Teaching Award in 2001, 2002 and 2003.

Professor Antony is a fellow of the American College of Physicians and the Royal College of Physicians and Surgeons, as well as the Infectious Diseases Society of America and the Royal Society of Medicine. He is heavily involved in HIV and AIDS education, and acts as a scientific reviewer for several journals, including his activities as the associate editor of El Paso Physician since 2001.

Professor Antony also acts as an infectious disease consultant at the Center for Infectious Diseases and Travel Medicine, in El Paso, Texas.

Prof. Dr. Héctor Mora-Montes

Prof. Dr. Mora-Montes

Department of Biology, Division of Natural and Exact Sciences, University of Guanajuato, Guanajuato, Mexico

During his post as a clinical analyst, Prof. Mora-Montes developed a system for the differentiation of Candida species, based on in-house zymograms and colony morphology in cornmeal agar. As a postgraduate student, he generated a new and innovative method for in situ determination of glycosyl hydrolase activities and received the “Summa Cum Laude” distinction from Universidad de Guanajuato. Among the most important achievements during his time as a postdoctoral fellow at the University of Aberdeen (Scotland), he set up most of the immunological techniques within the Aberdeen Fungal Group and developed and standardized protocols for the isolation and purification of chitin, phospholipomannan, N-linked and O-linked mannans from fungal cells. Those protocols have not only benefited the Aberdeen Fungal Group, but other international groups dedicated to the study of the fungal cell wall, and are considered among the most popular and standardized methods for isolation and analysis of fungal cell wall components.

In 2010, he established the Laboratory of Fungal Glycobiology at Universidad de Guanajuato (Mexico), with the main goal to understand the mechanisms behind the fungal cell wall synthesis and the interaction of medically relevant fungal pathogens with the host. This laboratory is characterized by its facilities to perform chemical, immunological, genetic, molecular and cellular analyses of human fungal pathogens. Therefore, it is among a handful of research facilities within Mexico and Latin America offering a multidisciplinary and integral approach to understand these pathogens. Currently, the group is developing molecular tools for genetic manipulation of medically relevant fungi, in particular Sporothrix and Candida species. Our group has a solid international reputation in the genetic study of these organisms, in the immune sensing of fungal cells, and the development of alternative models to analyze fungal virulence.

Since 2016, he was awarded the level III distinction by SNI, the highest distinction awarded by the Mexican Government for Mexican Researchers under 65 years old. He currently holds editorial appointments in several peer-reviewed international journals and is the Deputy President of the Latin-American Society of Glycobiology.

Professor Sandip Patil

Professor Patil

Department of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen, China

Dr. Sandip Patil is an accomplished Molecular Microbiologist with a strong focus on combating bacterial infectious diseases. His expertise lies in understanding the molecular intricacies of WHO priority list pathogens and their antibacterial resistance mechanisms. He is dedicated to unravelling these complexities to develop effective strategies against resistance, discover novel antimicrobial molecules, and improve treatment outcomes.

Currently serving as a Researcher at Shenzhen Children's Hospital in Shenzhen, China, Dr. Patil actively contributes to research projects in infection epidemiology and clinical molecular microbiology. He has a proven track record of developing and implementing advanced diagnostic workflows that integrate local metadata and public health surveillance data to address urgent epidemiological questions related to outbreaks and antimicrobial resistance. Notably, Dr. Patil specializes in studying the impact of β-lactamase inhibitors, hydrolyzing cephalosporins, mutations on β-lactamase expression, and colistin resistance.

Dr. Patil's journey in molecular microbiology began with a Ph.D. in Microbiology (Bacteriology) from Shoolini University, Solan, India. His doctoral research focused on conducting extensive molecular characterization of methicillin-resistant Staphylococcus aureus strains carrying mec-SSC-IV cassettes associated with the toxin encoding pvl gene. This experience deepened his understanding of genetic factors contributing to antibiotic resistance and fueled his commitment to developing effective treatment strategies.

Throughout his career, Dr. Patil has held various research and academic positions, including a Post-Doc Scientist and an assistant professor. He has received international recognition for his research capabilities and has been honored with the Bill and Melinda Gates Young Investigator Award. Dr. Patil is also an esteemed member of the Global Burden of Diseases Collaborative network. His research findings have been published in high-impact scientific journals, including The Lancet Microbes, and he has presented his work at numerous national and international conferences.

Dr. Patil's dedication to scientific advancement is evident through his active engagement with scientific literature and his participation in conferences and workshops. He has successfully fostered collaborations with renowned scientists and institutions worldwide, further contributing to the global scientific community.

Dr Zhi Ruan

Dr Ruan

Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China

Dr. Zhi Ruan is a principal investigator in the field of microbial genomics and bioinformatics at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, China. He has been awarded the National Science Foundation for Distinguished Young Scholars of Zhejiang Province. Dr. Ruan's research revolves around the study of multidrug-resistant bacterial pathogens, including notorious culprits such as Acinetobacter, Klebsiella, Escherichia, and Salmonella. By employing genome sequencing, phylogenetics, spatiotemporal analysis, and epidemiology, his team delves into the evolution and transmission of these pathogens, with a particular emphasis on hospital-associated and foodborne infections.

One pressing concern that drives Dr. Ruan's work is the global health crisis of antimicrobial resistance. His group utilizes genomic epidemiology strategies to unravel the evolutionary history and global dissemination of multidrug-resistant pathogens. By studying the mechanisms behind antimicrobial resistance, they strive to develop new bioinformatics tools for prospective surveillance and tracking of bacterial pathogens of public health and medical significance. His research findings have been published in renowned scientific journals, including The Lancet Infectious Diseases, Nucleic Acids Research, and Drug Resistance Updates.

Furthermore, Dr. Ruan's innovative spirit led him to develop a revolutionary bacterial whole genome sequencing and source tracking database called BacWGSTdb. This comprehensive platform provides a one-stop solution for epidemiological outbreak analysis, allowing for the swift identification and tracking of bacterial pathogens. BacWGSTdb has pioneered the movement of whole genome sequencing from proof-of-concept studies to routine use in clinical microbiology laboratories. This breakthrough has transformed the way researchers and clinicians approach the analysis and management of infectious diseases, enabling more effective surveillance and control measures.

Beyond his research endeavors, Dr. Ruan's expertise is sought after by scientific journals, where he serves as an associate editor for prominent publications such as Travel Medicine and Infectious Disease, BMC Genomics, New Microbes and New Infections, Frontiers in Microbiology, Frontiers in Genetics, Scientific Reports, and PLoS ONE. Through his editorial roles, he actively contributes to the rigorous evaluation and dissemination of impactful research, cementing his position in the field of microbial genomics and bioinformatics.

Dr. Ruan's commitment to advancing the understanding of bacterial pathogens and antimicrobial resistance is paving the way for innovative approaches to tackle these urgent global challenges. With his expertise and passion, he continues to contribute significantly to the field of microbial genomics and bioinformatics, leaving an indelible mark on the scientific community.

Editorial Board

Itzhak Brook, GUMC Adjunct Professor, Georgetown University School of Medicine, Washington, D.C, USA

Keertan Dheda, Director: Centre for Lung Infection and Immunity, University of Cape Town, South Africa; Professor of Mycobacteriology and Global Health, London School of Hygiene and Tropical Medicine, London, UK 

Professor Jonathan Dinman, Professor and Affiliate Fellow, Virus Adaptation and Treatment, University of Maryland, College Park, MD, United States

Varsha Gupta, Professor, Department of Microbiology, Governmental Medical College and Hospital, Chandigarh, India

Irena Kostova, Professor, Department of Chemistry, Faculty of Pharmacy, Medical University, Sofia, Bulgaria

Junya Kuroda, Professor, Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan

Prof Mercy Jemima Newman, Associate Professor of Medical Microbiology, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Accra, Ghana, West Africa

Todd Primm, Professor, Department of Biological Sciences, Sam Houston State University, Texas, TX, USA

George R. Thompson, Professor of Medicine, Department of Medicine, Division of Infectious Diseases, Department of Medical Microbiology and Immunology, University of California, Davis Medical Center, Sacramento, CA, USA

Min Wu, Professor, Director of Human Tissue Core, Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, USA and Wenzhou Institute of University of Chinese Academy of Sciences, Wenzhou, Zhejiang, China